Enzyme Engineering's Quantum Leap Forward The biotech industry has long been plagued by inefficiencies in enzyme engineering, a process critical to drug development and various industrial applications.
Imperagen, a startup founded by scientists from the Manchester Institute of Biotechnology, is attempting to revolutionize this field with its innovative use of quantum physics based simulations and AI models.
A £5 million seed round led by PXN Ventures has brought fresh capital to Imperagen's efforts to accelerate enzyme engineering.